Atossa Therapeutics
ATOS
#10738
Rank
โ‚ฌ19.11 M
Marketcap
1,92ย โ‚ฌ
Share price
0.47%
Change (1 day)
163.61%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚ฌ32.45 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚ฌ31.13 Million a decrease over its 2024 earnings that were of -โ‚ฌ22.84 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ32.45 Million4.21%
2025 -โ‚ฌ31.13 Million36.33%
2024 -โ‚ฌ22.84 Million-15.25%
2023 -โ‚ฌ26.95 Million11.62%
2022 -โ‚ฌ24.14 Million30.84%
2021 -โ‚ฌ18.45 Million15.58%
2020 -โ‚ฌ15.97 Million3.41%
2019 -โ‚ฌ15.44 Million51.16%
2018 -โ‚ฌ10.22 Million40.41%
2017 -โ‚ฌ7.28 Million27.54%
2016 -โ‚ฌ5.71 Million-47.49%
2015 -โ‚ฌ10.86 Million-17.25%
2014 -โ‚ฌ13.13 Million35.91%
2013 -โ‚ฌ9.66 Million112.3%
2012 -โ‚ฌ4.55 Million46.53%
2011 -โ‚ฌ3.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ16.76 B-49,745.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.33 B-4,056.62%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.30 B-3,958.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ37.31 M-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ29.49 Million-12.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ7.03 Million-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA